Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Serum Amylase as a Biomarker for Proof-of-Concept Studies in Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prevention

Clinical Gastroenterology and Hepatology(2022)10.1016/j.cgh.2022.08.020Source: DataRank Database

Serum Amylase as a Biomarker for Proof-of-Concept Studies in Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prevention is a research paper published in Clinical Gastroenterology and Hepatology (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.55)OA: greenTopics (26)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Paul J. Nietert ORCID,John F.G. Bobo,Mona Haj,Nauzer Forbes ORCID,B. Joseph Elmunzer ORCID

Live enrichment

PubMed:36029968 PMC:PMC9958270 OpenAlex:https://openalex.org/W4293050973

National Institutes of Health

Grant: 1P30-DK123704

NIDDK NIH HHS

Grant: P30 DK123704

National Institute of Diabetes and Digestive and Kidney Diseases

FWCI

0.55

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9958270

publisherhttps://api.elsevier.com/content/article/PII:S1542356522008163?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1542356522008163?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cgh.2022.08.020

Fields of Study

Gallbladder and Bile Duct DisordersPancreatic and Hepatic Oncology ResearchPancreatitis Pathology and TreatmentHumansCholangiopancreatography, Endoscopic RetrogradePancreatitisRisk FactorsBiomarkersAmylases

MeSH Terms

AmylasesCholangiopancreatography, Endoscopic RetrogradeHumansPancreatitisRisk FactorsBiomarkers

Keywords

MedicineEndoscopic retrograde cholangiopancreatographyRandomized controlled trialPancreatitisScopusRepurposingHyperamylasemiaInternal medicineMEDLINEGastroenterologyAmylase

Sustainable Development Goals

SDG 0: Good health and well-being